BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 19 filers reported holding BELLEROPHON THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $0 | – | 500 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 500 | -60.3% | 0.00% | – |
Q2 2019 | $0 | – | 1,258 | +151.6% | 0.00% | – |
Q1 2019 | $0 | – | 500 | 0.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 500 | 0.0% | 0.00% | – |
Q3 2018 | $1,000 | -88.9% | 500 | -86.1% | 0.00% | – |
Q2 2018 | $9,000 | +800.0% | 3,588 | +617.6% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | -50.0% | 500 | -50.0% | 0.00% | – |
Q1 2017 | $2,000 | – | 1,000 | 0.0% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 1,000 | +100.0% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q4 2015 | $1,000 | -98.9% | 500 | -97.3% | 0.00% | – |
Q3 2015 | $95,000 | -68.6% | 18,379 | -51.9% | 0.00% | – |
Q2 2015 | $303,000 | +56.2% | 38,194 | +80.7% | 0.00% | – |
Q1 2015 | $194,000 | – | 21,137 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Puissance Capital Management LP | 8,298,755 | $6,651,000 | 7.59% |
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. | 15,138,486 | $16,953,000 | 1.88% |
VHCP Management II, LLC | 4,149,378 | $3,325,000 | 1.43% |
VHCP Management III, LLC | 2,274,370 | $1,823,000 | 1.32% |
ARCH Venture Management, LLC | 965,660 | $774,000 | 0.77% |
A.R.T. Advisors, LLC | 30,484 | $24,000 | 0.00% |
Virtu Financial LLC | 36,708 | $29,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,000 | $147,000 | 0.00% |
GABLES CAPITAL MANAGEMENT INC. | 1,400 | $1,000 | 0.00% |
Renaissance Technologies | 1,255,476 | $1,006,000 | 0.00% |